MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14744/anatoljcardiol.2016.6752

Медицинская библиотека · Anatolian journal of cardiology · 2016

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).

Başaran Özcan, Beton Osman, Doğan Volkan, Tekinalp Mehmet, Aykan Ahmet Çağrı, Kalaycıoğlu Ezgi, Bolat İsmail, Taşar Onur, Şafak Özgen, Kalçık Macit, Yaman Mehmet, Altun İbrahim, Soylu Mustafa Özcan, Kırma Cevat, Biteker Murat, RAMSES Study

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF patients in the era of non-VKA oral anticoagulants (NOACs).

METHODS

We established a cross-sectional, multicenter, nationwide registry of NVAF patients. All consecutive atrial fibrillation (AF) patients and without mechanical heart valves or rheumatic mitral stenosis (but including those with any degree of mitral regurgitation) were enrolled in the ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies (RAMSES Study; ClinicalTrials.gov identifier NCT02344901) in Turkey. Baseline demographic data, medical history, and medications prescribed for NVAF treatment were collected. Univariate analyses were performed for continuous variables, and the chi-square test was used for categorical variables.

RESULTS

In total, 6273 patients from 29 provinces of Turkey were enrolled in the study between February and May 2015, with the contribution of 83 investigators. The mean age was 69.6±10.7 years; 56% of the patients were females, and one-fifth of the patients had at least one comorbid disease, the most common being hypertension (69%). The mean CHA2DS2-VASc and HAS-BLED scores were 3.3±1.6 and 1.6±1.1, respectively. The rate of oral anticoagulant (OAC) therapy use was 72% (37% NOAC and 35% VKA).

CONCLUSION

The RAMSES study showed a higher prevalence of OAC use among NVAF patients than that reported in previous studies. Although NOACs were preferred over VKAs in daily cardiology practice, there is a need for improved OAC therapies for NVAF patients.

Для цитирования: Başaran Özcan, Beton Osman, Doğan Volkan, Tekinalp Mehmet, Aykan Ahmet Çağrı, Kalaycıoğlu Ezgi, Bolat İsmail, Taşar Onur, Şafak Özgen, Kalçık Macit, Yaman Mehmet, Altun İbrahim, Soylu Mustafa Özcan, Kırma Cevat, Biteker Murat, RAMSES Study. ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).. Anatolian journal of cardiology. 2016. DOI: 10.14744/anatoljcardiol.2016.6752.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.